Document text
Principal Investigator: BALI PULENDRAN
Organization: STANFORD UNIVERSITY
Fiscal Year: 2023
Award: $512,494
Funding agency: National Institute of Allergy and Infectious Diseases
ABSTRACT – Project 1
In the current proposal, we will use systems biological approaches to address two fundamental issues in
vaccinology. The first issue concerns the immunology of COVID-19 vaccines, which utilize novel platforms
(mRNA) or adjuvants (Matrix M used in the Novavax vaccine). The second issue is related to the role of the
microbiome on vaccine immunity. With respect to the first issue, despite the rapid development of COVID-
19 vaccines, there is a paucity of understanding about the mechanisms by which they induce innate and
adaptive responses. Furthermore, the nature of the immune response induced by mRNA vaccines in special
populations such as those with serious allergies is unknown. It is conceivable that in such populations, a
predisposition towards Th2 responses, could alter the quality of the immune response. Interestingly,
there have been reports of rare but severe allergic reactions to vaccination, in individuals with an atopic
background. Therefore, we will assess immunity to the BNT162b2 vaccine atopic versus healthy subjects. In
the case of the Matrix-M adjuvanted recombinant COVID-19 vaccine developed by Novavax, there is a
paucity of understanding of innate immune mechanisms stimulated by the saponin-based Matrix-M adjuvant.
We will analyze samples collected from a Novavax sponsored clinical trial of their investigational subunit
COVID-19 vaccine in South African adults.
The second theme of the proposal is focused on the impact of the microbiome on immunity to
vaccination in healthy adults. Our recent work involving antibiotics driven ablation of the microbiota has
highlighted an important role for the microbiome in modulating immune responses to vaccination with the
seasonal influenza vaccine. However, the immune response against seasonal influenza vaccine in adults
represents a recall response, because of prior exposure to influenza. The impact of the microbiome on a
primary immune response, such as the response to rabies vaccination, is unknown. These issues will be
addressed in the following specific aims:
Aim 1: Systems biological assessment of innate responses to vaccination against COVID-19.
Sub-aim 1a: Multi-omics assessment of innate responses to the BNT162b2 mRNA vaccine in atopic vs.
healthy adults.
Sub-aim 1b: Multi-omics assessment of innate responses to the Novavax COVID-19 vaccine.
Aim 2: Systems biological assessment of the impact of the microbiota on innate immunity to rabies
vaccination.
Terms: <2019-nCoV vaccine><21+ years old><Ablation><Address><Adjuvant><Adult><Adult Human><Allergic Reaction><Allergy><Antibiotic Agents><Antibiotic Drugs><Antibiotics><Antibody Response><Antiviral resistance><Antiviral resistant><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><BNT 162b2><BNT162b2><Blood Plasma><Blood Serum><Blood monocyte><Booster Immunization><COVID-19 vaccination><COVID-19 vaccine><COVID19 vaccination><COVID19 vaccine><Cell Body><Cells><Clinical Trials><Cytometry><Dendritic Cells><Dengue><Development><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Exposure to><FNA><Fine Needle Aspirate><Fine needle aspiration biopsy><Fine-Needle Aspiration><Frequencies><GI microbiota><Gastrointestinal microbiota><Grippe><H5N1><H5N1 virus><Human><Hypersensitivity><Immune response><Immunity><Immunochemical Immunologic><Immunologic><Immunological><Immunological response><Immunologically><Immunologics><Immunology><Immunomodulation><Impairment><Individual><Influenza><Influenza A Virus, H5N1 Subtype><Influenza Vaccines><Innate Immune Response><Innate Immunity><Lymph Node Reticuloendothelial System><Lymph node proper><Lymphatic nodes><Marrow monocyte><Memory><Messenger RNA><Miscellaneous Antibiotic><Modern Man><Molecular Fingerprinting><Molecular Profiling><Myelogenous><Myeloid><Myeloid Cells><Native Immunity><Natural Immunity><Nature><Non-Specific Immunity><Nonspecific Immunity><Novavax COVID-19 vaccine><Novavax S protein vaccine><Novavax coronavirus disease 2019 vaccine><PBMC><Peripheral Blood Mononuclear Cell><Pfizer-BioNTech COVID-19 vaccine><Pfizer-BioNTech coronavirus disease 2019 vaccine><Plasma><Plasma Serum><Population><Predisposition><RNA vaccine><RNA-based vaccine><Rabies><Rabies Human Diploid Cell Vaccine><Rabies Vaccines><Rabies virus><Recombinants><Reporting><Resistance><Reticuloendothelial System, Serum, Plasma><Role><SARS-CoV-2 rS><SARS-CoV-2 vaccination><SARS-CoV-2 vaccine><SARS-CoV2 vaccine><SARS-coronavirus-2 vaccine><Sampling><Saponins><Secondary Immunization><Serum><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe acute respiratory syndrome coronavirus 2 vaccination><Severe acute respiratory syndrome coronavirus 2 vaccine><South Africa><South African><Special Population><Susceptibility><System><Vaccinated><Vaccination><Vaccines><Veiled Cells><Viral><Virus><Work><ZIKA><adaptive immune response><adaptive immunity><adult youth><adulthood><anti-viral resistance><anti-viral resistant><antigen-specific T cells><avian influenza H5N1><avian influenza H5N1 virus><biological systems><booster vaccination><corona virus disease 2019 vaccine><coronavirus disease 2019 vaccination><coronavirus disease 2019 vaccine><coronavirus disease-19 vaccine><cytokine><develop a vaccine><develop vaccines><development of a vaccine><developmental><enteric microbial community><enteric microbiota><epigenetically><epigenomics><flu vaccine><flu virus pandemic><flu virus vaccine><gastrointestinal microbial flora><gut commensal><gut community><gut flora><gut microbe community><gut microbial community><gut microbial composition><gut microbial consortia><gut microbiota><gut microbiotic><gut microflora><host response><immune modulation><immune regulation><immune system response><immunogenicity><immunologic reactivity control><immunomodulatory><immunoregulation><immunoregulatory><immunoresponse><imprint><influenza virus pandemic><influenza virus vaccine><innate immune mechanisms><insight><intestinal flora><intestinal microbes><intestinal microbiota><intestinal microflora><intestinal tract microflora><lymph gland><lymph nodes><lymphnodes><lyssa><mRNA><mRNA vaccine><mRNA-based vaccine><metabolism measurement><metabolomics><metabonomics><microbial consortia><microbial flora><microbiome><microbiota><microflora><molecular profile><molecular signature><monocyte><multiomics><multiple omics><multispecies consortia><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><novel><pandemic flu><pandemic influenza><pandemic strain of influenza><resistant><response><seasonal flu><seasonal influenza><social role><transcriptomics><vaccinate against COVID-19><vaccinate against COVID19><vaccinate against SARS-CoV-2><vaccinate against coronavirus disease 2019><vaccinate against severe acute respiratory syndrome coronavirus 2><vaccination against COVID-19><vaccination against COVID19><vaccination against SARS-CoV-2><vaccination against Severe acute respiratory syndrome coronavirus 2><vaccination against coronavirus disease 2019><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine against flu><vaccine against influenza><vaccine development><vaccine for novel coronavirus><vaccinology><young adult><young adulthood>